Joinn Laboratories(China)CoInterim net profit of 748 million yuan reported, indicating strong profitability.

Joinn Laboratories has released its 2026 interim report. Total operating revenue was 704 million yuan, net profit attributable to the parent company was 748 million yuan, and net operating cash inflow was 457 million yuan. The latest asset-liability ratio was 17.09 percent, up 2.35 percentage points from the previous quarter and up 2.65 percentage points from the same period last year. Gross margin was 23.76 percent, ranking 41st among disclosed peer companies, down 0.27 percentage points from a year earlier. Return on equity was 8.33 percent, and diluted earnings per share was 1.00 yuan. Total asset turnover was 0.07 times and inventory turnover was 0.33 times, both lower than the same period last year. The company had 74,400 shareholders, and the top ten shareholders held 54.37 percent of total share capital.
Joinn Laboratories(China)CoInterim net profit of 748 million yuan reported, indicating strong profitability.